Transfemoral transcatheter aortic valve replacement with VitaFlowTM valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial
Authors:
- 25 February 2024
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 271, 76-83
Abstract
No abstract availableKeywords
Funding Information
- Microport Scientific Corporation
This publication has 22 references indexed in Scilit:
- Transcatheter Treatment of Native Aortic Valve RegurgitationJACC: Cardiovascular Interventions, 2023
- Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United StatesJACC, 2021
- Transcatheter Aortic Valve Replacement in Aortic RegurgitationThe Annals of Thoracic Surgery, 2020
- TAVR in Patients with Pure Aortic Regurgitation: Ready to Use?Current Cardiology Reports, 2020
- Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry)The American Journal of Cardiology, 2019
- Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta‐analysisClinical Cardiology, 2018
- Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve RegurgitationThe American Journal of Cardiology, 2018
- Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve RegurgitationJACC, 2017
- Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve ReplacementJAMA Cardiology, 2017
- Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical BioprosthesesJACC: Cardiovascular Interventions, 2017